How is the Invivyd Inc today?

The Invivyd Inc today is trading in the down by -2.06% at 0.95.

How has Invivyd Inc performed historically?

The Invivyd Inc is currently trading down -2.06% on an intraday basis in the past week the index rose 5.56%. The index has been up 1.06% in the past quarter and fell -47.51% in the past year. You can view this in the overview section.

What is Invivyd Inc Annual Net Profit?

Invivyd Inc Annual Net Profit rose 14.46% in the last year to $169.92 M. Its sector's average net profit growth for the last fiscal year was -13.88%.

What is Invivyd Inc Price to Earning Ratio?

Invivyd Inc Price to Earning Ratio is -0.8, which is negative.

What is Invivyd Inc Stock Price?

Invivyd Inc Stock Price fell 47.51% and underperformed its sector by 78.8% in the past year.

What is Invivyd Inc Quarterly Net profit?

Invivyd Inc Quarterly Net profit rose 62.55% YoY to $16.29 M. Its sector's average net profit growth YoY for the quarter was -238.37%.

What is Invivyd Inc Debt to Equity Ratio?

Invivyd Inc Debt to Equity Ratio of 0.02 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Invivyd Inc Return on Equity(ROE)?

Invivyd Inc Return on Equity(ROE) for the last financial year was -138.71%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Invivyd Inc Mutual Fund Holding?

Invivyd Inc Mutual Fund Holding decreased by 1.81% in the last quarter to 13.13.

What is Invivyd Inc Institutional Holding?

Invivyd Inc Institutional Holding decreased by 5.2% in the last quarter to 58.48.

Invivyd Inc XNAS: IVVD

Invivyd Inc Live Share Price Today, Share Analysis and Chart

Name: Invivyd Inc: Is Infosys Ltd. worth buying?
Item: Invivyd Inc
Rating: 1.163430625
Author: Trendlyne DVM scores

Momentum Trap

about

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the ...

0.95 -0.02 (-2.06%)

65.33% Fall from 52W High

533.3K XNAS Volume

XNAS 04 Jun, 2025 12:08 PM (EDT)

Low Financial Strength

5.6 / 100

Expensive Valuation

19.3 / 100

Technically Moderately Bullish

62.6 / 100

Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM

1Yr Price target upside is 419%

3 analysts

Invivyd Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Invivyd Inc Live Share Price Today, Share Analysis and Chart

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the ...

65.33% Fall from 52W High

SWOT Analysis

Invivyd Inc Live Price Chart

Invivyd Inc FAQ

How is Invivyd Inc today?

Invivyd Inc today is trading in the red, and is down by -2.06% at 0.95.

How has Invivyd Inc performed historically?

Invivyd Inc is currently trading down -2.06% on an intraday basis. In the past week the stock rose 5.56%. stock has been up 1.06% in the past quarter and fell -47.51% in the past year. You can view this in the overview section.